People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| selectIon, Inc. | — | Biotechnology | Series A | $19.6M | $16.1M | 2019 |
| OCP Collective Corp. | — | Other Technology | Series A | $6.7M | $138.7M | 2011 |
Mark Wiggins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Wiggins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Frankel | 1 | 30 |
| Peter Flint | 1 | 14 |
| John F. Frankel | 1 | 9 |
| Michael Foster | 1 | 8 |
| Cam Gallagher | 1 | 7 |
| Antonius Schuh | 1 | 5 |
| Steve Zaniboni | 1 | 3 |
| Don Scifres | 1 | 2 |
| Stephen Zaniboni | 1 | 2 |
| Andreas Klostermann | 1 | 1 |
| Don Scrifes | 1 | 1 |
| Robert Cromer | 1 | 1 |
| Robert Prentice | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.